צמיחת הכנסות ב-12 חודשים נגררים: Capricor Therapeutics (CAPR)

The financial stability of Capricor Therapeutics (CAPR) depends on grants and the results of new drug trials. The LTM annual sales growth rate on the GURU.Markets chart reflects revenue dynamics, where the metric level stands at -99.90. The company is currently scaling production to combat Duchenne muscular dystrophy, strictly adhering to bioethical standards and the principles of sustainable laboratory development.
Capricor Therapeutics Inc. (CAPR) - פילוחי מדדים ודוחות פיננסיים

This indicator measures rolling year revenue dynamics, neutralizing quarterly volatility through a daily recalculation of turnover growth rates. Analyzing the YoY sales growth over the last four quarters on GURU.Markets is critical for Capricor Therapeutics (CAPR), as it reflects the transition from a cost-intensive cell technology development phase to a high-margin commercialization stage for approved therapies.